Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma
Clinical trial NCT00896480 · COMPLETED
Trial details
- NCT number
- NCT00896480
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-19
- Primary completion
- 2014-11-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.